Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Type 2 Diabetes in Parkinson's Disease
Dilan Athauda, James R. Evans, Anna I. Wernick, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1612-1623
Open Access | Times Cited: 72

Showing 26-50 of 72 citing articles:

Perspectives of nurses and patients on the misplacement of supportive care information for type 2 diabetes mellitus: a qualitative study in China
Ying Li, Chao Li, Na Zhou, et al.
BMC Nursing (2025) Vol. 24, Iss. 1
Open Access
The obesity pandemic and its impact on non-communicable disease burden
Staffan Hildebrand, Alexander Pfeifer
Pflügers Archiv - European Journal of Physiology (2025)
Open Access
Parkinson's disease and glucose metabolism impairment
Liangjing Chen, Chunyu Wang, Lixia Qin, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Associations of the Life’s Essential 8 with Parkinson’s disease: a population-based study
Chenguang Zhou, Oumei Cheng
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Parkinson’s disease and metabolic disorders, understanding their shared co-morbidity through the autonomic nervous system
Thanh Pham, Rebecca E. Schelling, Ken H. Loh
Advances in genetics (2025)
Closed Access
Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review
Vítor Tumas, Marcelo Jhonatan Aureliano, Carlos Roberto de Mello Rieder, et al.
Arquivos de Neuro-Psiquiatria (2025) Vol. 83, Iss. 03, pp. 001-010
Open Access
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Anika Vear, Michael T. Heneka, Christoffer Clemmensen
Nature Metabolism (2025)
Closed Access
Plasma and urinary metabolomic signatures differentiate genetic and idiopathic Parkinson’s disease
Juliana Cordovil Cotrin, Gilson Costa dos Santos, André Simões Cadaxo, et al.
Brain Research (2025) Vol. 1858, pp. 149625-149625
Closed Access
Association of cholesterol and glycemic state biomarkers with phenotypic variation and Parkinson's disease progression: The Oxford Discovery cohort
Nicholas K. H. Chiu, Michael Lawton, Tanja Zerenner, et al.
Journal of Parkinson s Disease (2025)
Open Access
Efficacy of Mucuna pruriens (L.) DC. in treating diabetes, Parkinson’s disease, and erectile dysfunction—a review of clinical and preclinical trials
Ravindra Verma, Vaibhav Misra, Prakash S. Bisen
(2025) Vol. 3
Open Access
Exploring Risk and Protective Factors in Parkinson’s Disease
Iman Beheshti
Cells (2025) Vol. 14, Iss. 10, pp. 710-710
Open Access
Association between Type 1 Diabetes Mellitus and Parkinson’s Disease: A Mendelian Randomization Study
Aaron Shengting, Brendan Jen‐Wei Tan, Qiao-Yang Sun, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 561-561
Open Access | Times Cited: 3
The impact of diabetes mellitus on the development of psychiatric and neurological disorders
Olivia G. Kelly, Jillian Sullivan, Natalie Carris, et al.
Brain Disorders (2024) Vol. 14, pp. 100135-100135
Open Access | Times Cited: 3
Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
Jingchuan Guo, Huilin Tang, Hui Shao, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 3
Increasing incidence of Parkinson's disease in patients with epilepsy: A Nationwide cohort study
Yun Su Hwang, Min Gu Kang, Sang Woo Yeom, et al.
Journal of the Neurological Sciences (2024) Vol. 458, pp. 122891-122891
Closed Access | Times Cited: 2
Racial disparities in hospitalization characteristics among Native Hawaiians, Pacific Islanders and Asian American subgroups with Parkinson's disease
Michiko Kimura Bruno, Masako Matsunaga, Emma Krening, et al.
Parkinsonism & Related Disorders (2024) Vol. 121, pp. 106018-106018
Open Access | Times Cited: 2
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De, Yung‐Chih Kuo
Journal of the Taiwan Institute of Chemical Engineers (2024) Vol. 157, pp. 105401-105401
Closed Access | Times Cited: 2
Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities
Mohd Faizan, Alika Sarkar, Mahendra Pratap Singh
Ageing Research Reviews (2022) Vol. 81, pp. 101727-101727
Closed Access | Times Cited: 11
Parkinson’s Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility
Yun Yan, Dhanush Shimoga, Amol Sharma
Current Gastroenterology Reports (2023) Vol. 25, Iss. 5, pp. 106-113
Closed Access | Times Cited: 6
The comorbidity and co-medication profile of patients with progressive supranuclear palsy
Stephan Greten, Florian Wegner, Ida Jensen, et al.
Journal of Neurology (2023) Vol. 271, Iss. 2, pp. 782-793
Open Access | Times Cited: 6
Parkinson’s Disease and Diabetes Mellitus: Individual and Combined Effects on Motor, Cognitive, and Psychosocial Functions
Jolie Barter, Dwaina Thomas, Liang Ni, et al.
Healthcare (2023) Vol. 11, Iss. 9, pp. 1316-1316
Open Access | Times Cited: 5
Long-term diabetic hyperglycaemia modifies social behaviour in rats
Justine Renaud, Alexandre Clouet, Giulia Costa, et al.
Endocrine and Metabolic Science (2024) Vol. 16, pp. 100197-100197
Open Access | Times Cited: 1
Metformin Attenuates Manganese-Induced Oxidative Stress in N27-A Dopaminergic Neuronal Cells
Jae‐Sung Kim, Jeong-Yeon Seo, Kyeong‐Rok Kang, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 2, pp. 539-546
Open Access | Times Cited: 1
GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression
Dilan Athauda, James R. Evans, Laura Mahoney‐Sanchez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Understanding the link between type 2 diabetes mellitus and Parkinson’s disease: role of brain insulin resistance
Theodora Ntetsika, Sergiu‐Bogdan Catrina, Ioanna Markaki
Neural Regeneration Research (2024) Vol. 20, Iss. 11, pp. 3113-3123
Open Access | Times Cited: 1

Scroll to top